搜尋結果
We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer, and infectious diseases and other serious diseases. As immune engineers we have a deep understanding of the underlying mechanisms that enable the immune system to effectively recognize both external threats like infectious diseases and internal threats like cancer.
BioNTech SE ( 德语发音: [ˈbaɪɒnˌtek] ; NASDAQ : BNTX )被译为 生物新技术公司 或 拜恩泰科 [2] [3] ,是一家位于 德国 美因茨 的生物技术公司,主要業務為开发和生产针对特定患者的治疗严重疾病的有效 免疫治疗 [1] 。. 它开发基于 信使核糖核酸 (mRNA ...
BioNTech SE ( 德語發音: [ˈbaɪɒnˌtek] ; NASDAQ : BNTX )被譯為 生物新技術公司 或 拜恩泰科 [2] [3] ,是一家位於 德國 美茵茲 的生物技術公司,主要業務為開發和生產針對特定患者的治療嚴重疾病的有效 免疫治療 [1] 。. 它開發基於 信使核糖核酸 (mRNA)的候選 ...
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [12] and Christoph Huber, [13] with a seed investment of €150 million from MIG Capital and AT Impf. [14] The company's activities focus on the development and production of technologies and drugs for individualized cancer immunotherapy. [3]
2022年4月1日 · 根據輝瑞/BioNTech公司在《新英格蘭醫學雜誌》上公布的三期臨牀試驗結果,在兩劑接種間隔期間,疫苗的有效性達到52%;在第二劑疫苗接種後的7天內 ...
2021年8月24日 · 美國食品藥品監督管理局(FDA)已全面批准輝瑞/BioNTech新冠疫苗,這也是第一支在美國獲得全面授權的新冠疫苗。 美國此前授權該疫苗緊急使用,兩 ...
2021年1月25日 · 食物及衞生局局長今日(一月二十五日)根據《預防及控制疾病(使用疫苗)規例》(第599K章)(《規例》),認可復星醫藥/德國藥廠BioNTech的新冠疫苗(即Comirnaty COVID-19 mRNA Vaccine(BNT162b2)Concentrate for Dispersion for Injection)在香港作緊急使用。. 根據《規例 ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer
2020年11月13日 · The novel platform on which BioNTech’s vaccine is based, known as mRNA, injects genetic instructions into the body — a method never before used in a licensed pharmaceutical © BioNTech
2020年11月18日 · BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.